HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$0.14
Day range
$0.14 - $0.14
Year range
$0.14 - $1.52
Market cap
28.10M USD
Avg Volume
7.61M
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.94M | — |
Operating expense | 9.51M | -23.06% |
Net income | -5.82M | 63.66% |
Net profit margin | -117.78 | — |
Earnings per share | 0.00 | 100.00% |
EBITDA | -4.55M | 62.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.17M | 12.34% |
Total assets | 52.74M | -0.21% |
Total liabilities | 44.24M | 11.37% |
Total equity | 8.50M | — |
Shares outstanding | 1.20B | — |
Price to book | 14.26 | — |
Return on assets | -22.95% | — |
Return on capital | -32.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.82M | 63.66% |
Cash from operations | -9.82M | 0.77% |
Cash from investing | 10.18M | 148.35% |
Cash from financing | -1.22M | -134.81% |
Net change in cash | -787.00K | 66.89% |
Free cash flow | -7.91M | -14.83% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
79
